Related Experiment Video
Updated: Dec 9, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Impact of COVID-19 on Acute Stroke Presentation at a Comprehensive Stroke Center
Masaki Nagamine1, Daniel S Chow2,3, Peter D Chang2,3
1Department of Neurology, University of California, Irvine Medical Center, Orange, CA, United States.
Insights
The COVID-19 pandemic led to fewer acute stroke patients presenting at hospitals and increased delays in treatment. This highlights the need to adapt stroke care protocols during public health crises to ensure timely interventions.
Area of Science:
- Neurology
- Public Health
- Emergency Medicine
Background:
- The COVID-19 pandemic significantly altered healthcare delivery, impacting the presentation and management of acute stroke.
- Timely thrombolysis is critical for acute ischemic stroke outcomes, making pandemic-related delays a serious concern.
Purpose of the Study:
- To evaluate the impact of the early COVID-19 pandemic on acute ischemic stroke presentation and care.
- To compare stroke incidence, patient arrival times, and outcomes during the initial months of the pandemic versus the previous year.
Main Methods:
- Retrospective review of electronic medical records for acute ischemic stroke patients.
- Comparison of data from March-April 2020 (early COVID-19) with March-April 2019.
- Assessment of stroke incidence, last known well to arrival times, and mortality rates.
Main Results:
- Fewer acute ischemic stroke cases presented in March-April 2020 (48) compared to 2019 (64).
- Average last known well to arrival time significantly increased in 2020 (1041 min) versus 2019 (554 min).
- A lower percentage of patients presented within the critical 4.5-hour window in 2020 (27.8%) compared to 2019 (40.5%), with a higher mortality rate (10.4% vs. 6.3%).
Conclusions:
- The early COVID-19 period saw reduced acute stroke presentations and delayed treatment times.
- Pandemic conditions necessitate optimizing stroke triage algorithms to ensure timely and effective care.
- Understanding pandemic effects on stroke presentation is crucial for maintaining standards of care during health crises.
Abstract:
Background: COVID-19 has impacted healthcare in many ways, including presentation of acute stroke. Since time-sensitive thrombolysis is essential for reducing morbidity and mortality in acute stroke, any delays due to the pandemic can have serious consequences. Methods: We retrospectively reviewed the electronic medical records for patients presenting with acute ischemic stroke at a comprehensive stroke center in March-April 2020 (the early months of COVID-19) and compared to the same time period in 2019. Stroke metrics such as incidence, time to arrival, and immediate outcomes were assessed. Results: There were 48 acute ischemic strokes (of which 7 were transfers) in March-April 2020 compared to 64 (of which 12 were transfers) in 2019. The average last known well to arrival time (±SD) for stroke codes was 1,041 (±1682.1) min in 2020 and 554 (±604.9) min in 2019. Of the patients presenting directly to the ED with a known last known well time, 27.8% (10/36) presented in the first 4.5 h in 2020, in contrast to 40.5% (15/37) in 2019. Patients who died comprised 10.4% of the stroke cohort in 2020 (5/48) compared to 6.3% in 2019 (4/64). Conclusions: During the first 2 months of COVID-19, there were fewer overall stroke cases who presented to our hospital, and of these cases, there was delayed presentation in comparison to the same time period in 2019. Recognizing how stroke presentation may be affected by COVID-19 would allow for optimization of established stroke triage algorithms in order to ensure safe and timely delivery of stroke care during a pandemic.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
Atherosclerosis IV: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies

